Abascal-Saiz A, Sotillo-Mallo L, de Santiago J, Zapardiel I. Management of borderline ovarian tumours: a comprehensive review of the literature. Ecancermedicalscience. 2014;8:403.

Google Scholar 

Koensgen D, Weiss M, Assmann K, Brucker SY, Wallwiener D, Stope MB, et al. Characterization and Management of Borderline Ovarian Tumors - results of a retrospective, single-center study of patients treated at the Department of Gynecology and Obstetrics of the university medicine Greifswald. Anticancer Res. 2018;38:1539–45.

Google Scholar 

du Bois A, Ewald-Riegler N, de Gregorio N, Reuss A, Mahner S, Fotopoulou C, et al. Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) study group. Eur J Cancer. 2013;49:1905–14.

Article  Google Scholar 

Araujo KG, Jales RM, Pereira PN, Yoshida A, de Angelo AL, Sarian LO, et al. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center. Ultrasound Obstet Gynecol. 2017;49:778–83.

Article  CAS  Google Scholar 

Gershenson DM. Management of borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2017;41:49–59.

Article  Google Scholar 

Tropé CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26:325–36.

Article  Google Scholar 

Lalwani N, Shanbhogue AKP, Vikram R, Nagar A, Jagirdar J, Prasad SR. Current update on borderline ovarian neoplasms. AJR Am J Roentgenol. 2010;194:330–6.

Article  Google Scholar 

Trillsch F, Mahner S, Ruetzel J, Harter P, Ewald-Riegler N, Jaenicke F, et al. Clinical management of borderline ovarian tumors. Expert Rev Anticancer Ther. 2010;10:1115–24.

Article  CAS  Google Scholar 

Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017;470:125–42.

Article  CAS  Google Scholar 

du Bois A, Trillsch F, Mahner S, Heitz F, Harter P. Management of borderline ovarian tumors. Ann Oncol. 2016;27:i20–2 [cited 2021 Jun 16]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0923753419316199.

Article  Google Scholar 

Wagner U, Reuß A. S3-Leitlinie “Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren”: Leitlinienprogramm Onkologie, Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF: Langversion 3.0, 2019, AWMF-Registernummer: 032/035OL. Forum. 2019;34:413–5 [cited 2021 Jun 16]. Available from: http://link.springer.com/10.1007/s12312-019-00671-4.

Article  Google Scholar 

Faluyi O, Mackean M, Gourley C, Bryant A, Dickinson HO. Interventions for the treatment of borderline ovarian tumours. Cochrane Database Syst Rev. 2010;2010(9):CD007696. https://doi.org/10.1002/14651858.CD007696.pub2.

Meinhold-Heerlein I, Fotopoulou C, Harter P, Kurzeder C, Mustea A, Wimberger P, et al. Statement by the Kommission Ovar of the AGO: the new FIGO and WHO classifications of ovarian, fallopian tube and primary peritoneal Cancer. Geburtshilfe Frauenheilkd. 2015;75:1021–7.

Article  CAS  Google Scholar 

Prat J, Committee FIGO, on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124:1–5.

Article  Google Scholar 

May J, Skorupskaite K, Congiu M, Ghaoui N, Walker GA, Fegan S, et al. Borderline ovarian tumors: fifteen years’ experience at a Scottish tertiary Cancer center. Int J Gynecol Cancer. 2018;28:1683–91.

Article  Google Scholar 

Ren J, Peng Z, Yang K. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Gynecol Oncol. 2008;110:162–7.

Article  Google Scholar 

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol. 2001;83:575–85.

Article  CAS  Google Scholar 

Ji H, Yliskoski M, Anttila M, Syrjänen K, Saarikoski S. Management of stage-I borderline ovarian tumors. Int J Gynaecol Obstet. 1996;54:37–44.

Article  CAS  Google Scholar 

Desfeux P, Camatte S, Chatellier G, Blanc B, Querleu D, Lécuru F. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol. 2005;98:390–5.

Article  Google Scholar 

Pirimoglu ZM, Afsin Y, Guzelmeric K, Yilmaz M, Unal O, Turan MC. Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors? Arch Gynecol Obstet. 2008;277:411–4.

Article  Google Scholar 

Wong HF, Low JJH, Chua Y, Busmanis I, Tay EH, Ho TH. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer. 2007;17:342–9.

Article  CAS  Google Scholar 

Ayhan A, Guven S, Guven ESG, Kucukali T. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? Acta Obstet Gynecol Scand. 2007;86:484–90.

Article  CAS  Google Scholar 

Yüksel D, Çakır C, Kimyon Cömert G, Kılıç Ç, Durmuş Y, Boran N, et al. Uncommon borderline ovarian tumours: a clinicopathologic study of seventeen patients. J Turk Ger Gynecol Assoc. 2019;20:224–30.

Article  Google Scholar 

Jia S-Z, Zhang J-J, Liang Z-Y, Yang J-J, Xiang Y, Jia C-W, et al. Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours. BMC Cancer. 2018;18:1160.

Article  Google Scholar 

Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol. 2006;101:255–60.

Article  Google Scholar 

Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, et al. Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecol Oncol. 1992;46:226–9.

Article  CAS  Google Scholar 

Verta S, Kipp B. Ultraconservative, fertility sparing treatment of bilateral borderline ovarian tumors: a case report of a 26-year-old, 0-gravida with an Endometrioid borderline ovarian tumor of the right ovary and a Sero-mucinous borderline ovarian tumor of the left ovary and a review of the literature. Int J Women's Health. 2020;12:601–11.

Article  Google Scholar 

Hogg R, Scurry J, Kim S-N, Friedlander M, Hacker N. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma. Gynecol Oncol. 2007;106:44–51.

Article  Google Scholar 

Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol. 2000;95:541–7.

CAS  Google Scholar 

Fauvet R, Boccara J, Dufournet C, Poncelet C, Daraï E. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol. 2005;16:403–10.

Article  CAS  Google Scholar 

Lenhard MS, Mitterer S, Kümper C, Stieber P, Mayr D, Ditsch N, et al. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. Eur J Obstet Gynecol Reprod Biol. 2009;145:189–94.

Article  Google Scholar 

Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer. 2006;42:149–58.

Article  CAS  Google Scholar 

Suh-Burgmann E. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol. 2006;103:841–7.

Article  Google Scholar 

Chan JK, Lin YG, Loizzi V, Ghobriel M, DiSaia PJ, Berman ML. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J Reprod Med. 2003;48:756–60.

Google Scholar 

Tinelli FG, Tinelli R, La Grotta F, Tinelli A, Cicinelli E, Schönauer MM. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors. Acta Obstet Gynecol Scand. 2007;86:81–7.

Article  CAS  Google Scholar 

Trillsch F, Mahner S, Vettorazzi E, Woelber L, Reuss A, Baumann K, et al. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study. Br J Cancer. 2015;112:660–6.

Article  CAS  Google Scholar 

Camatte S, Morice P, Thoury A, Fourchotte V, Pautier P, Lhomme C, et al. Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer. 2004;40:1842–9.

Article  Google Scholar 

McKenney JK, Balzer BL, Longacre TA. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. Am J Surg Pathol. 2006;30:614–24.

Article  Google Scholar